Literature DB >> 17873490

Atrial fibrillation and antithrombotic therapy in a 75-year-old population.

Arnljot Tveit1, Michael Abdelnoor, Steve Enger, Pal Smith.   

Abstract

AIMS: To find the true prevalence of diagnosed and undiagnosed atrial fibrillation (AF) in a population aged 75 years in 2 municipalities in Norway, and to study the use of antithrombotic therapy in this group.
METHODS: All 1,117 citizens in Asker and Baerum municipalities in eastern Norway born in 1930 were invited to participate in a prevalence study of AF. Nine hundred and sixteen subjects (82%) were examined by electrocardiogram, and blood pressure and pulse rate were measured. Comorbidity and current medication were recorded.
RESULTS: AF was present in 92 subjects (10%; 95% CI 8.2-12.1%), including 33 with ECG-documented, paroxysmal AF. In addition, 8 subjects had a history of a single, transient episode of AF. AF was previously undiagnosed in 10 out of 916 (1.1%). In 77 of 82 patients with previously diagnosed AF (93.9%), antithrombotic therapy was compliant with international guidelines.
CONCLUSION: Ten percent (95% CI 8.2-12.2%) in this 75-year-old population had AF. Compliance with international guidelines regarding antithrombotic therapy was high. Previously undiagnosed AF was found in only 10 out of 916 (1.1%). 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873490     DOI: 10.1159/000107789

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  10 in total

1.  Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015.

Authors:  Lars J Kjerpeseth; Hanne Ellekjær; Randi Selmer; Inger Ariansen; Kari Furu; Eva Skovlund
Journal:  Eur J Clin Pharmacol       Date:  2017-07-22       Impact factor: 2.953

2.  Quality of Life, Exercise Capacity and Comorbidity in Old Patients with Permanent Atrial Fibrillation.

Authors:  Inger Ariansena; Knut Gjesdala; Michael Abdelnoorb; Elisabeth Edvardsenc; Steve Engerd; Arnljot Tveitd
Journal:  J Atr Fibrillation       Date:  2008-12-01

3.  Predictors of incident atrial fibrillation and influence of medications: a retrospective case-control study.

Authors:  James A Hodgkinson; Clare J Taylor; F D Richard Hobbs
Journal:  Br J Gen Pract       Date:  2011-06       Impact factor: 5.386

4.  Physical activity, symptoms, medication and subjective health among veteran endurance athletes with atrial fibrillation.

Authors:  Marius Myrstad; Marit Aarønæs; Sidsel Graff-Iversen; Inger Ariansen; Wenche Nystad; Anette Hylen Ranhoff
Journal:  Clin Res Cardiol       Date:  2015-07-26       Impact factor: 5.460

5.  Increased risk of atrial fibrillation among elderly Norwegian men with a history of long-term endurance sport practice.

Authors:  M Myrstad; M-L Løchen; S Graff-Iversen; A K Gulsvik; D S Thelle; H Stigum; A H Ranhoff
Journal:  Scand J Med Sci Sports       Date:  2013-11-21       Impact factor: 4.221

6.  Asymmetric Dimethylarginine Levels are Highly Associated With Atrial Fibrillation in an Elderly Population.

Authors:  Ingebjorg Seljeflot; Sara R Ulimoen; Steve Enger; Vibeke Bratseth; Harald Arnesen; Arnljot Tveit
Journal:  Cardiol Res       Date:  2012-05-20

7.  Screening for Atrial Fibrillation Using a Smartphone-Based Electrocardiogram in Korean Elderly.

Authors:  Nu Ri Kim; Chang Kyun Choi; Hyeong-Suk Kim; Su-Hyun Oh; Jung-Hwa Yang; Ki Hong Lee; Ju Han Kim; Man-Seok Park; Hye-Yeon Kim; Min-Ho Shin
Journal:  Chonnam Med J       Date:  2020-01-22

8.  Refined atrial fibrillation screening and cost-effectiveness in the German population.

Authors:  Renate B Schnabel; Christopher Wallenhorst; Daniel Engler; Stefan Blankenberg; Norbert Pfeiffer; Ngoc Anh Spruenker; Matthias Buettner; Matthias Michal; Karl J Lackner; Thomas Münzel; Philipp S Wild; Carlos Martinez; Ben Freedman
Journal:  Heart       Date:  2021-08-10       Impact factor: 5.994

9.  Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participation.

Authors:  Johan Engdahl; Anders Holmén; Mårten Rosenqvist; Ulf Strömberg
Journal:  BMC Public Health       Date:  2013-08-03       Impact factor: 3.295

10.  Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects.

Authors:  Odd Erik Johansen; Ellen Brustad; Steve Enger; Arnljot Tveit
Journal:  Cardiovasc Diabetol       Date:  2008-09-28       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.